4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001193125-25-325355
Director sold 1,694,614 shares at an average $23.05 ($39,065,213)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANCHESTER KEITH S Director | 2025-12-16 | Sale | −275,000 | $22.93 | $6,305,750 | 17,772,727 | I |
| MANCHESTER KEITH S Director | 2025-12-16 | Sale | −642,282 | $23.08 | $14,823,869 | 17,130,445 | I |
| MANCHESTER KEITH S Director | 2025-12-17 | Sale | −432,718 | $23.05 | $9,974,150 | 16,697,727 | I |
| MANCHESTER KEITH S Director | 2025-12-17 | Sale | −155,076 | $23.02 | $3,569,850 | 16,542,651 | I |
| MANCHESTER KEITH S Director | 2025-12-17 | Sale | −189,538 | $23.17 | $4,391,595 | 16,353,113 | I |
| Open-market sales · 1,694,614 sh · avg $23.05 · $39,065,213 | |||||||
Loading xslF345X05/ownership.xml…